The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term capital growth and current income primarily through investments in non-U.S. stocks.
The fund normally invests at least 80% of its net assets (including any borrowings for investment purposes) in equity securities and invests at least 65% of its total assets in non-U.S. stocks, with an emphasis on large-cap stocks that have a strong track record of paying dividends or that are believed to be undervalued.
The average market capitalization across the T. Rowe Price International Value Eq Z MF is 138.2B. The market cap for tickers in the group ranges from 20B to 197.73B. AZN holds the highest valuation in this group at 197.73B. The lowest valued company is RYCEF at 20B.
The average weekly volume growth across all stocks in the T. Rowe Price International Value Eq Z MF was -20%. For the same stocks of the MF, the average monthly volume growth was -45% and the average quarterly volume growth was -37%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 37
P/E Growth Rating: 53
Price Growth Rating: 47
SMR Rating: 39
Profit Risk Rating: 59
Seasonality Score: 18 (-100 ... +100)